Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
3R01NS048125-04S1
Application #
7394568
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Program Officer
Conwit, Robin
Project Start
2004-04-01
Project End
2008-03-31
Budget Start
2007-04-01
Budget End
2008-03-31
Support Year
4
Fiscal Year
2007
Total Cost
$64,200
Indirect Cost
Name
Columbia University (N.Y.)
Department
Neurology
Type
Schools of Medicine
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Montes, J; McDermott, M P; Martens, W B et al. (2010) Six-Minute Walk Test demonstrates motor fatigue in spinal muscular atrophy. Neurology 74:833-8
Kaufmann, Petra; Thompson, John L P; Levy, Gilberto et al. (2009) Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III. Ann Neurol 66:235-44
Armon, Carmel (2009) Smoking may be considered an established risk factor for sporadic ALS. Neurology 73:1693-8
Buchsbaum, Richard; Kaufmann, Petra; Barsdorf, Alexandra I et al. (2009) Web-based data management for a phase II clinical trial in ALS. Amyotroph Lateral Scler 10:374-7
Gwinn, Katrina; Corriveau, Roderick A; Mitsumoto, Hiroshi et al. (2007) Amyotrophic lateral sclerosis: an emerging era of collaborative gene discovery. PLoS One 2:e1254
Kaufmann, Petra; Levy, Gilbero; Montes, Jacquelina et al. (2007) Excellent inter-rater, intra-rater, and telephone-administered reliability of the ALSFRS-R in a multicenter clinical trial. Amyotroph Lateral Scler 8:42-6
Levy, G; Kaufmann, P; Buchsbaum, R et al. (2006) A two-stage design for a phase II clinical trial of coenzyme Q10 in ALS. Neurology 66:660-3